Clinical significance of ASB9 in human colorectal cancer

  • Authors:
    • Masayoshi Tokuoka
    • Norikatsu Miyoshi
    • Toshiki Hitora
    • Koshi Mimori
    • Fumiaki Tanaka
    • Koichi Shibata
    • Hideshi Ishii
    • Mitsugu Sekimoto
    • Yuichiro Doki
    • Masaki Mori
  • View Affiliations

  • Published online on: November 1, 2010     https://doi.org/10.3892/ijo_00000762
  • Pages: 1105-1111
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ankyrin repeat and SOCS box-containing 9 (ASB9) is involved in the negative regulation of cytokine signaling. However, its biological function is largely undefined. The aim of this study was to assess the value and role of ASB9 as an indicator of prognosis in colorectal cancer (CRC). In order to demonstrate the importance of ASB9 expression for predicting the prognosis of CRC, we analyzed the ASB9 mRNA expression in 125 paired cases of CRC and non-cancerous regions and the protein expression by immunohistochemistry. To investigate the role of ASB9 in vitro, we performed proliferation and invasion assay with small interfering RNA against ASB9. ASB9 mRNA expression was higher in CRC tissue than corresponding normal tissue (P=0.0282). Patients expressing low levels of ASB9 had a poorer overall survival rate than those expressing high levels (P=0.0301), indicating that decreased ASB9 expression was an independent prognostic factor. The immunohistochemical study revealed that ASB9 was predominantly expressed in cancer cells. A multivariate analysis showed that ASB9 expression status was an independent prognostic factor of overall survival (relative risk, 4.09; 95% confidence interval, 1.47-11.88; P=0.007). In an invasion assay, ASB9 siRNA-transfected cells showed significantly high invasiveness. The results of the present study suggest that ASB9 is a useful prognostic marker for CRC.

Related Articles

Journal Cover

November 2010
Volume 37 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K, Ishii H, Sekimoto M, Doki Y, Mori M, Mori M, et al: Clinical significance of ASB9 in human colorectal cancer. Int J Oncol 37: 1105-1111, 2010
APA
Tokuoka, M., Miyoshi, N., Hitora, T., Mimori, K., Tanaka, F., Shibata, K. ... Mori, M. (2010). Clinical significance of ASB9 in human colorectal cancer. International Journal of Oncology, 37, 1105-1111. https://doi.org/10.3892/ijo_00000762
MLA
Tokuoka, M., Miyoshi, N., Hitora, T., Mimori, K., Tanaka, F., Shibata, K., Ishii, H., Sekimoto, M., Doki, Y., Mori, M."Clinical significance of ASB9 in human colorectal cancer". International Journal of Oncology 37.5 (2010): 1105-1111.
Chicago
Tokuoka, M., Miyoshi, N., Hitora, T., Mimori, K., Tanaka, F., Shibata, K., Ishii, H., Sekimoto, M., Doki, Y., Mori, M."Clinical significance of ASB9 in human colorectal cancer". International Journal of Oncology 37, no. 5 (2010): 1105-1111. https://doi.org/10.3892/ijo_00000762